Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Correction of linear system drifts in magnetic particle imaging.

Knopp T, Gdaniec N, Rehr R, Graeser M, Gerkmann T.

Phys Med Biol. 2019 Jun 20;64(12):125013. doi: 10.1088/1361-6560/ab2480.

PMID:
31125983
2.

Human-sized magnetic particle imaging for brain applications.

Graeser M, Thieben F, Szwargulski P, Werner F, Gdaniec N, Boberg M, Griese F, Möddel M, Ludewig P, van de Ven D, Weber OM, Woywode O, Gleich B, Knopp T.

Nat Commun. 2019 Apr 26;10(1):1936. doi: 10.1038/s41467-019-09704-x.

3.

Bimodal intravascular volumetric imaging combining OCT and MPI.

Latus S, Griese F, Schlüter M, Otte C, Möddel M, Graeser M, Saathoff T, Knopp T, Schlaefer A.

Med Phys. 2019 Mar;46(3):1371-1383. doi: 10.1002/mp.13388. Epub 2019 Feb 14.

PMID:
30657597
4.

Moving table magnetic particle imaging: a stepwise approach preserving high spatio-temporal resolution.

Szwargulski P, Gdaniec N, Graeser M, Möddel M, Griese F, Krishnan KM, Buzug TM, Knopp T.

J Med Imaging (Bellingham). 2018 Oct;5(4):046002. doi: 10.1117/1.JMI.5.4.046002. Epub 2018 Nov 27.

PMID:
30525063
5.

Magnetic Particle Imaging for Real-Time Perfusion Imaging in Acute Stroke.

Ludewig P, Gdaniec N, Sedlacik J, Forkert ND, Szwargulski P, Graeser M, Adam G, Kaul MG, Krishnan KM, Ferguson RM, Khandhar AP, Walczak P, Fiehler J, Thomalla G, Gerloff C, Knopp T, Magnus T.

ACS Nano. 2017 Oct 24;11(10):10480-10488. doi: 10.1021/acsnano.7b05784. Epub 2017 Oct 4.

PMID:
28976180
6.

Towards Picogram Detection of Superparamagnetic Iron-Oxide Particles Using a Gradiometric Receive Coil.

Graeser M, Knopp T, Szwargulski P, Friedrich T, von Gladiss A, Kaul M, Krishnan KM, Ittrich H, Adam G, Buzug TM.

Sci Rep. 2017 Jul 31;7(1):6872. doi: 10.1038/s41598-017-06992-5.

7.

Hybrid system calibration for multidimensional magnetic particle imaging.

von Gladiss A, Graeser M, Szwargulski P, Knopp T, Buzug TM.

Phys Med Biol. 2017 May 7;62(9):3392-3406. doi: 10.1088/1361-6560/aa5340. Epub 2017 Apr 5.

PMID:
28378709
8.

Two dimensional magnetic particle spectrometry.

Graeser M, von Gladiss A, Weber M, Buzug TM.

Phys Med Biol. 2017 May 7;62(9):3378-3391. doi: 10.1088/1361-6560/aa5bcd. Epub 2017 Jan 31.

PMID:
28140373
9.

Magnetic particle imaging: current developments and future directions.

Panagiotopoulos N, Duschka RL, Ahlborg M, Bringout G, Debbeler C, Graeser M, Kaethner C, Lüdtke-Buzug K, Medimagh H, Stelzner J, Buzug TM, Barkhausen J, Vogt FM, Haegele J.

Int J Nanomedicine. 2015 Apr 22;10:3097-114. doi: 10.2147/IJN.S70488. eCollection 2015. Review.

10.

Electronic field free line rotation and relaxation deconvolution in magnetic particle imaging.

Bente K, Weber M, Graeser M, Sattel TF, Erbe M, Buzug TM.

IEEE Trans Med Imaging. 2015 Feb;34(2):644-51. doi: 10.1109/TMI.2014.2364891. Epub 2014 Oct 24.

PMID:
25350924
11.

Magnetic particle imaging: kinetics of the intravascular signal in vivo.

Haegele J, Duschka RL, Graeser M, Schaecke C, Panagiotopoulos N, Lüdtke-Buzug K, Buzug TM, Barkhausen J, Vogt FM.

Int J Nanomedicine. 2014 Sep 3;9:4203-9. doi: 10.2147/IJN.S49976. eCollection 2014.

12.

Supplemental screening ultrasound increases cancer detection yield in BRCA1 and BRCA2 mutation carriers.

Bosse K, Graeser M, Goßmann A, Hackenbroch M, Schmutzler RK, Rhiem K.

Arch Gynecol Obstet. 2014 Mar;289(3):663-70. doi: 10.1007/s00404-013-3022-6. Epub 2013 Sep 18.

PMID:
24045978
13.

Comparison of Open Scanner Designs for Interventional Magnetic Particle Imaging.

Wojtczyk H, Bringout G, Tenner W, Graeser M, Grüttner M, Sattel TF, Gräfe K, Haegele J, Duschka RL, Panagiotopoulos N, Vogt FM, Barkhausen J, Buzug TM.

Biomed Tech (Berl). 2013 Aug;58 Suppl 1. pii: /j/bmte.2013.58.issue-s1-L/bmt-2013-4279/bmt-2013-4279.xml. doi: 10.1515/bmt-2013-4279. Epub 2013 Sep 7. No abstract available.

PMID:
24042921
14.

High Homogeneous Saddle Drive Field Coil for Magnetic Particle Spectroscopy.

Graeser M, Sattel T, Buzug TM.

Biomed Tech (Berl). 2013 Aug;58 Suppl 1. pii: /j/bmte.2013.58.issue-s1-L/bmt-2013-4260/bmt-2013-4260.xml. doi: 10.1515/bmt-2013-4260. Epub 2013 Sep 7. No abstract available.

PMID:
24042912
15.

Platelet-derived growth factor receptor beta serum concentrations during first-line therapy in ovarian cancer.

Mathey S, Graeser MK, Zu Eulenburg C, Woelber L, Trillsch F, Jaenicke F, Müller V, Milde-Langosch K, Mahner S.

Oncology. 2013;85(2):69-77. doi: 10.1159/000351032. Epub 2013 Jul 16.

PMID:
23860180
16.

Noninvasive detection of HER2 amplification with plasma DNA digital PCR.

Gevensleben H, Garcia-Murillas I, Graeser MK, Schiavon G, Osin P, Parton M, Smith IE, Ashworth A, Turner NC.

Clin Cancer Res. 2013 Jun 15;19(12):3276-84. doi: 10.1158/1078-0432.CCR-12-3768. Epub 2013 May 1.

17.

Analog receive signal processing for magnetic particle imaging.

Graeser M, Knopp T, Grüttner M, Sattel TF, Buzug TM.

Med Phys. 2013 Apr;40(4):042303. doi: 10.1118/1.4794482.

PMID:
23556916
18.

Prognostic impact of fascin-1 (FSCN1) in epithelial ovarian cancer.

Hanker LC, Karn T, Holtrich U, Graeser M, Becker S, Reinhard J, Ruckhäberle E, Gevensleben H, Rody A.

Anticancer Res. 2013 Feb;33(2):371-7.

PMID:
23393326
19.

Androgen receptor expression is a predictive marker in chemotherapy-treated patients with endocrine receptor-positive primary breast cancers.

Witzel I, Graeser M, Karn T, Schmidt M, Wirtz R, Schütze D, Rausch A, Jänicke F, Milde-Langosch K, Müller V.

J Cancer Res Clin Oncol. 2013 May;139(5):809-16. doi: 10.1007/s00432-013-1382-8. Epub 2013 Feb 8.

PMID:
23392859
20.

The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study.

Rhiem K, Engel C, Graeser M, Zachariae S, Kast K, Kiechle M, Ditsch N, Janni W, Mundhenke C, Golatta M, Varga D, Preisler-Adams S, Heinrich T, Bick U, Gadzicki D, Briest S, Meindl A, Schmutzler RK.

Breast Cancer Res. 2012 Dec 7;14(6):R156. doi: 10.1186/bcr3369.

21.

Correlation of thyroid hormone, retinoid X, peroxisome proliferator-activated, vitamin D and oestrogen/progesterone receptors in breast carcinoma.

Ditsch N, Mayr D, Lenhard M, Strauss C, Vodermaier A, Gallwas J, Stoeckl D, Graeser M, Weissenbacher T, Friese K, Jeschke U.

Oncol Lett. 2012 Oct;4(4):665-671. Epub 2012 Jul 13.

22.

A retrospective investigation of women's experience with breast reconstruction after mastectomy.

Ditsch N, Bauerfeind I, Vodermaier A, Tripp C, Löhrs B, Toth B, Himsl I, Graeser M, Harbeck N, Lenhard M.

Arch Gynecol Obstet. 2013 Mar;287(3):555-61. doi: 10.1007/s00404-012-2590-1. Epub 2012 Oct 23.

PMID:
23090185
23.

Magnetic particle imaging: introduction to imaging and hardware realization.

Buzug TM, Bringout G, Erbe M, Gräfe K, Graeser M, Grüttner M, Halkola A, Sattel TF, Tenner W, Wojtczyk H, Haegele J, Vogt FM, Barkhausen J, Lüdtke-Buzug K.

Z Med Phys. 2012 Dec;22(4):323-34. doi: 10.1016/j.zemedi.2012.07.004. Epub 2012 Aug 19. Review.

PMID:
22909418
24.

A 24-color metaphase-based radiation assay discriminates heterozygous BRCA2 mutation carriers from controls by chromosomal radiosensitivity.

Becker AA, Graeser MK, Landwehr C, Hilger T, Baus W, Wappenschmidt B, Meindl A, Weber RG, Schmutzler RK.

Breast Cancer Res Treat. 2012 Aug;135(1):167-75. doi: 10.1007/s10549-012-2119-0. Epub 2012 Jun 23.

PMID:
22729890
25.

A marker of homologous recombination predicts pathologic complete response to neoadjuvant chemotherapy in primary breast cancer.

Graeser M, McCarthy A, Lord CJ, Savage K, Hills M, Salter J, Orr N, Parton M, Smith IE, Reis-Filho JS, Dowsett M, Ashworth A, Turner NC.

Clin Cancer Res. 2010 Dec 15;16(24):6159-68. doi: 10.1158/1078-0432.CCR-10-1027. Epub 2010 Aug 27.

26.

Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Graeser MK, Engel C, Rhiem K, Gadzicki D, Bick U, Kast K, Froster UG, Schlehe B, Bechtold A, Arnold N, Preisler-Adams S, Nestle-Kraemling C, Zaino M, Loeffler M, Kiechle M, Meindl A, Varga D, Schmutzler RK.

J Clin Oncol. 2009 Dec 10;27(35):5887-92. doi: 10.1200/JCO.2008.19.9430. Epub 2009 Oct 26.

PMID:
19858402
27.

Association of hormone receptor status with grading, age of onset, and tumor size in BRCA1-associated breast cancer.

Graeser M, Bosse K, Brosig M, Engel C, Schmutzler RK; German Consortium for Hereditary Breast and Ovarian Cancer.

Virchows Arch. 2009 May;454(5):519-24. doi: 10.1007/s00428-009-0760-8. Epub 2009 Apr 21.

PMID:
19381686

Supplemental Content

Loading ...
Support Center